MEG3 has been proposed as a tumor suppressor and a negative regulator of angiogenesis [30,31], and its down-regulation serves as an unfavorable risk factor for survival in multiple human cancer types [32–34], mainly by promoter and IG-DMR region hypermethylation [52]. Here, MEG3 is linked to cancer.